HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Superior mesenteric vein thrombosis — Clinical Guidelines

Overview

Superior mesenteric vein thrombosis (SMVT) is a serious condition characterized by the obstruction of blood flow in the superior mesenteric vein, often leading to bowel ischemia and potentially severe complications such as multiple-organ dysfunction syndrome (MODS) and short-bowel syndrome (SBS). 1

Diagnosis

Clinical Presentation: Symptoms include acute abdominal pain, nausea, vomiting, and signs of systemic inflammatory response.

Laboratory Tests: Elevated serum D-dimer levels within the first 3 days post-admission correlate with disease severity, including outcomes like MODS and SBS. 1

Imaging: CT angiography is crucial for definitive diagnosis, visualizing thrombus presence and extent.

Grading: No specific grading system mentioned in the provided abstracts; clinical severity often assessed via clinical scores and complications observed.

Management

Anticoagulation: Early initiation of anticoagulation therapy is critical to prevent further thrombus propagation and improve outcomes. Specific drug classes and doses not detailed in the abstracts.

Surgical Intervention: Indicated in cases of bowel necrosis, persistent ischemia, or failure of medical management; may include thrombectomy or bowel resection.

Supportive Care: Management of sepsis, fluid balance, and nutritional support tailored to individual patient needs.

Monitoring: Regular assessment of D-dimer levels to monitor disease progression and response to treatment. 1

Special Populations

Pregnancy: No specific data provided in the abstracts regarding SMVT management in pregnant women.

Pediatrics: No information available from the provided abstracts.

Elderly: No specific considerations or studies mentioned for elderly patients.

Comorbidities: Management strategies may need adjustment based on comorbidities, though specific guidance is not detailed in the abstracts.

Key Recommendations

Monitor serum D-dimer levels within the first 3 days post-admission to assess disease severity and predict complications such as MODS and SBS. (Evidence: Moderate) 1

Initiate anticoagulation therapy early in the management of SMVT to prevent further thrombus extension and improve patient outcomes. (Evidence: Expert opinion)

Consider surgical intervention for patients with signs of bowel necrosis, persistent ischemia, or failure of medical management. (Evidence: Expert opinion)

References

1 Yang S, Fan X, Ding W, Liu B, Meng J, Wang K et al.. D-dimer as an early marker of severity in patients with acute superior mesenteric venous thrombosis. Medicine 2014. link 2 Klemm MF, Van Helden DF, Luff SE. Ultrastructural analysis of sympathetic neuromuscular junctions on mesenteric veins of the guinea pig. The Journal of comparative neurology 1993. link

Superior mesenteric vein thrombosis